SAM
TSBX

Sectoral Asset Management’s Turnstone Biologics TSBX Stock Holding History

Sectoral Asset Management’s Portfolio TSBX Stock Details TSBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-517,648
Closed -$257K – 97
2024
Q4 		$257K Hold
517,648
– – 0.17% 67
2024
Q3 		$288K Hold
517,648
– – 0.17% 79
2024
Q2 		$1.36M Hold
517,648
– – 0.55% 50
2024
Q1 		$1.36M Hold
517,648
– – 0.53% 55
2023
Q4 		$1.32M Hold
517,648
– – 0.57% 60
2023
Q3 		$2.04M Buy
+517,648
New +$4.61M 0.4% 81

Other funds holding TSBX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sectoral Asset Management's TSBX Position: Q1 2025 in Review

Sectoral Asset Management sold out of Turnstone Biologics (TSBX) in Q1 2025, closing a stake of 517,648 shares — an estimated $257K sold.

Sectoral Asset Management first reported a position in TSBX in Q3 2023 and held it in 6 quarters. The position peaked at $2.04M in Q3 2023. 23 funds tracked by Wall St. Rank hold TSBX as of Q1 2025.

  • Sectoral Asset Management reported no remaining Turnstone Biologics position as of Q1 2025 after selling out during the quarter.
  • Sectoral Asset Management sold 517,648 Turnstone Biologics shares in Q1 2025, an estimated $257K.
  • Sectoral Asset Management first reported a position in Turnstone Biologics in Q3 2023 and held it in 6 quarters.
  • Sectoral Asset Management's Turnstone Biologics position peaked at $2.04M in Q3 2023.
  • 23 funds tracked by Wall St. Rank held Turnstone Biologics as of Q1 2025.

Based on Sectoral Asset Management's 13F filing for Q1 2025, filed 15 May 2025.